title: Management of hypertension in women.
abstract: A gender-specific approach to cardiovascular (CV) diseases has been practiced for decades, although not always to the advantage of women. Based on population data showing that women are at lower risk for CV events than men female gender has generally been regarded as a protective factor for CV disease. Unfortunately, CV risk assessment has therefore received less attention in women. Despite the lower absolute risk of CV events in women compared with age-matched men, the majority of women die from CV diseases. In absolute numbers, since 1984, more women than men died of CV disease each year. Most CV events occur in women with known traditional CV risk factors. Improving risk factor management in women of all ages therefore yields an enormous potential to reduce CV morbidity and mortality in the population. Aside from smoking cessation, hypertension (HTN) control is the single most important intervention to reduce the risk of future CV events in women. This review highlights peculiarities of HTN as they pertain to women, and points out where diagnosis and management of HTN may require a gender-specific focus.
authors.affiliation: Emory University School of Medicine, Grady Memorial Hospital, Atlanta, GA, USA.
authors.forename: Niels
authors.initials: N
authors.lastname: Engberding
authors.forename: Nanette K
authors.initials: NK
authors.lastname: Wenger
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D019468:Disease Management; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D015994:Incidence; D015995:Prevalence; D012307:Risk Factors; D012727:Sex Characteristics; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents